Accelerate to discover
Related topics
Cytek Biosciences hits flow cytometry milestone: 40 color analysis from a single sample
Oct 17, 2019
Cytek Aurora turning aspirations into realizations: 40 Colors, One Tube. Until recently, developing fluorescence-based...
Vascular imaging using a contrast-enhanced microCT approach
Oct 14, 2019
Are you interesting in MicroangioCT? Do you heard about Vascular imaging using a contrast-enhanced microCT approach?...
Change the way you process cells with Curiox Laminar Wash systems
Oct 8, 2019
Laminar Wash technology is for scientists who believe that quantitative flow cytometry is critical to cell therapy,...
Acquisition and analysis of reproducible high-complexity cytometry data using the Cytek Aurora
Oct 8, 2019
We invite you to join us on Friday, October 11 at 8:00 PM CET to hear more about Cytek collaborative...
Webinar recording - Highly sensitive structural variant detection for medical genetics
Oct 4, 2019
Follow the webinar outlining how a team at Radboud University Medical Center is assessing ultra-long read optical...
What if NMR was easy? Aspects & applications of the Fourier 80 FT-NMR benchtop spectrometer
Oct 1, 2019
What if there was a NMR instrument everybody could operate, that is as easy to use as infrared spectroscopy and as easy...
Sep 30, 2019
Enjoy an evening to meet with Cytek technical application specialists and technical sales representatives and share...
Sep 27, 2019
VisualSonics AutoLV allow functional and anatomical analysis of the left ventricle in one click using the power of...
Mar 22, 2016
The mutations driving cancer create clonal populations that differ not just between cancer patients, but within individual tumors. These mutations contain small but significant populations which may survive treatment and metastasize. The only method to get a complete picture of tumor clonality is by sequencing single cells.
In this webinar, you will learn how you can make breakthrough discoveries in your research using single-cell DNA Sequencing. Dr. Ioannis Ragoussis of McGill University will share his research using single-cell whole exome sequencing to reveal the true heterogeneity and cell lineages present in triple negative breast cancer.
Brand profile
Fluidigm is a Molecular and Single Cell Biology company that creates microfluidic-based chips and instrumentation for Life-Science research.
More info at:
www.fluidigm.com/
BioFocus newsletter
Register to receive Brand new technology development, Important product updates, Interesting scientific events and more!
BioTech a.s. © 2014
Designed & developed by imagineit
Technologies
